Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors
Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy
BioNxt Advances "Melt in Your Mouth" Cladribine Formulation to Improve Treatment for MS Patients with Dysphagia
Bausch Health Announces Early Exchange Offer Results for Exchange Offers
Rocket Doctor AI, CAN Health Network enter partnership
Izotropic to issue 240,000 units for note interest
TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients
Well Health's Wellstar closes $62-million financing
Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI(TM) (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML
NetraAI Study Accepted for Publication in npj Digital Medicine, Part of the Nature Portfolio
Rocket Doctor AI, Health Cities and CAN Health Network Partner to Advance AI-Powered Clinical Decision Support in Alberta
Aptose releases tuspetinib triple drug therapy data
WELL Subsidiary WELLSTAR Technologies Closes $62M Financing to Support Its Pre-Spinout Growth Strategy
Cheelcare Has a Record Month of Sales and Celebrates Milestone of 2,000 Companions Sold
ZYUS Life Sciences Provides Update on Clinical Trial Progress and Unit Private Placement